Aerosolized plus intravenous polymyxin B in comparison to intravenous polymyxin B alone for the management of HAP caused by carbapenem-resistant gram-negative bacteria: A prospective multicenter cohort study

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 905aeb4bba701588-LAX IP: 47.97.18.252 UTC time: 2025-01-21T23:00:12+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4